Sertoli-Leydig Cell Tumor as a Cause of Elevated 17-OH Progesterone.
17OH progesterone
Sertoli-Leydig cell tumor
hyperandrogenism
nonclassic CAH
oligomenorrhea
testosterone
Journal
JCEM case reports
ISSN: 2755-1520
Titre abrégé: JCEM Case Rep
Pays: England
ID NLM: 9918609886906676
Informations de publication
Date de publication:
Feb 2024
Feb 2024
Historique:
received:
24
10
2023
medline:
6
2
2024
pubmed:
6
2
2024
entrez:
6
2
2024
Statut:
epublish
Résumé
Virilizing ovarian tumors are rare but a clinically important diagnosis in a patient presenting with hyperandrogenism. Workup of hyperandrogenism is challenging with a broad range of differentials, including adrenal and ovarian pathology, tumoral or nontumoral in nature. Baseline follicular-phase 17-hydroxyprogesterone (17OHP) measurement is part of the investigation algorithm, and elevated levels are often associated with nonclassic congenital adrenal hyperplasia (NCCAH), which can have its first presentation in adolescence or adulthood. This case describes a young adult woman of reproductive age presenting with menstrual irregularity, raised testosterone, and 17OHP. After extensive workup and serial follow-up, she was found to have a Sertoli-Leydig cell tumor of the left ovary and underwent successful laparoscopic salpingo-oophorectomy with normalization of her menstrual irregularity and biochemical resolution of her testosterone and 17OHP levels.
Identifiants
pubmed: 38317845
doi: 10.1210/jcemcr/luae013
pii: luae013
pmc: PMC10843258
doi:
Types de publication
Case Reports
Langues
eng
Pagination
luae013Informations de copyright
© The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society.